PubRank

Manish A Shah

Author PubWeight™ 56.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. J Clin Oncol 2011 6.18
2 Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol 2005 3.02
3 Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial. J Clin Oncol 2012 2.45
4 Template for Reporting Results of HER2 (ERBB2) Biomarker Testing of Specimens From Patients With Adenocarcinoma of the Stomach or Esophagogastric Junction. Arch Pathol Lab Med 2014 2.02
5 Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Ann Surg Oncol 2010 1.85
6 Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors. J Clin Oncol 2005 1.82
7 Gastric cancer epidemiology and risk factors. J Surg Oncol 2012 1.82
8 Advanced gastric cancer--slow but steady progress. Cancer Treat Rev 2010 1.79
9 Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium. J Clin Oncol 2015 1.56
10 Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer. Cancer 2011 1.53
11 Gastric cancer--an enigmatic and heterogeneous disease. JAMA 2010 1.48
12 MET expression and amplification in patients with localized gastric cancer. Cancer Epidemiol Biomarkers Prev 2011 1.42
13 Thromboembolic events in gastric cancer: high incidence in patients receiving irinotecan- and bevacizumab-based therapy. J Clin Oncol 2005 1.18
14 Human epidermal growth factor receptor 2 testing in gastroesophageal cancer: correlation between immunohistochemistry and fluorescence in situ hybridization. Arch Pathol Lab Med 2011 1.14
15 Management of advanced gastric cancer. Expert Rev Gastroenterol Hepatol 2012 1.09
16 Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors. Clin Cancer Res 2009 1.08
17 Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma. Ann Surg Oncol 2014 1.01
18 Pneumatosis intestinalis: a variant of bevacizumab related perforation possibly associated with chemotherapy related GI toxicity. Invest New Drugs 2007 1.01
19 Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies. World J Gastroenterol 2011 0.99
20 Treatment of resectable gastric cancer. Therap Adv Gastroenterol 2012 0.99
21 Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. J Am Coll Surg 2008 0.98
22 Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer. Ann Surg Oncol 2012 0.95
23 Outcome of patients with known metastatic gastric cancer undergoing resection with therapeutic intent. Ann Surg Oncol 2007 0.95
24 Comparison of disease-specific survival in the United States and Korea after resection for early-stage node-negative gastric carcinoma. J Surg Oncol 2012 0.93
25 A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer. Cancer 2012 0.93
26 Combined modality therapy of esophageal cancer: changes in the standard of care? Ann Surg Oncol 2004 0.91
27 A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer. Pancreatology 2009 0.90
28 Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer. Cancer Chemother Pharmacol 2008 0.89
29 Is gastric cancer different in Korea and the United States? Impact of tumor location on prognosis. Ann Surg Oncol 2014 0.88
30 A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol. Cancer Chemother Pharmacol 2010 0.88
31 Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device. Lab Chip 2013 0.84
32 Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation. Am J Clin Oncol 2009 0.83
33 A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma. J Gastrointest Cancer 2011 0.80
34 Safety and efficacy of panitumumab following cetuximab: retrospective review of the Memorial Sloan-Kettering experience. Invest New Drugs 2009 0.80
35 Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach. Invest New Drugs 2014 0.79
36 Anaplastic thyroid cancer. Curr Opin Endocrinol Diabetes Obes 2015 0.78
37 The role of ¹⁸F-FDG PET imaging in upper gastrointestinal malignancies. Curr Treat Options Oncol 2014 0.78
38 Capecitabine in the treatment of esophageal and gastric cancers. Expert Opin Investig Drugs 2013 0.77
39 Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy. Ann Surg Oncol 2012 0.77
40 E-cadherin gene alterations in gastric cancers in different ethnic populations. Ethn Dis 2008 0.77
41 Phase II trial of cetuximab plus cisplatin and irinotecan in patients with cisplatin and irinotecan-refractory metastatic esophagogastric cancer. Am J Clin Oncol 2014 0.77
42 Met, IGF1R, and other new targets in upper GI malignancies. Curr Treat Options Oncol 2013 0.76
43 A case report of trastuzumab dose in gastric cancer. J Gastrointest Oncol 2013 0.76
44 Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Indian J Surg Oncol 2011 0.76
45 Single nucleotide polymorphisms in AREG and EREG are prognostic biomarkers in locally advanced gastric cancer patients after surgery with curative intent. Pharmacogenet Genomics 2014 0.75
46 The Quality of Quality-of-Life and Cost-Effectiveness Analyses. Gastrointest Cancer Res 2008 0.75
47 How should we care for elderly cancer patients? Oncology (Williston Park) 2009 0.75
48 Randomized clinical trials in gastric cancer. Surg Oncol Clin N Am 2010 0.75
49 A woman with remotely treated pancreas cancer and new abdominal pain: a discussion of evaluation and management. J Gastrointest Cancer 2011 0.75
50 Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients. Ann Surg 2016 0.75
51 Gastrointestinal cancer educational case series: management of metastatic adenocarcinoma of unknown primary origin in a Ph+ ALL survivor. J Gastrointest Cancer 2011 0.75
52 A man with Klinefelter's syndrome and new abdominal distension: a discussion of evaluation and management. J Gastrointest Cancer 2012 0.75
53 Staphylococcus aureus bacteremia in patients with neutropenia. South Med J 2002 0.75
54 Gastrointestinal cancer educational case series: the history and management of complex cases in gi oncology. A 72 year-old man with metastatic gastric cancer. J Gastrointest Cancer 2011 0.75
55 Gastrointestinal cancer educatinal case series: a 65 year-old female with locally advanced gastric cancer and a supraclavicular lymph node. J Gastrointest Cancer 2012 0.75